Lipocalin-2 (LCN2) is a glycoprotein that mediates multiple inflammatory processes and is elevated in serum of patients with active IBD, but decreases during periods of disease remission [14,15,16]. The gene discussed is LCN2; the disease is inflammatory bowel disease.